Paul Atkins, nominated by Trump, has been sworn in as SEC chair

Biolding Investment

investment firm

About

Biolding Investment

Details

Operating Status
Active

Investments

Number of Investments
Number of Lead Investments
1
0
Biolding Investment has made 1 investments. Their most recent investment was on Feb 27, 2012, when Amyris raised $83.70M.
Date Company Name
Round Money Raised Industry Lead Investor
Feb 27, 2012 Amyris
Post-IPO Equity $83.70M Biotechnology

Exits

Biolding Investment has had 1 exits. Biolding Investment most notable exits include Amyris

Date Company Name Exit Type Industry
Sep 28, 2010 Amyris IPO Biotechnology Detail